Eosinophils but Not of Neutrophils Stimulates Effector Functions of Human Interaction with Secretory Component
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Reference Ranges for Blood Concentrations of Eosinophils And
Journal of Perinatology (2010) 30, 540–545 r 2010 Nature America, Inc. All rights reserved. 0743-8346/10 www.nature.com/jp ORIGINAL ARTICLE Reference ranges for blood concentrations of eosinophils and monocytes during the neonatal period defined from over 63 000 records in a multihospital health-care system RD Christensen1,2, J Jensen1,3, A Maheshwari4 and E Henry1,3 1Intermountain Healthcare Women and Newborns Clinical Program, Ogden, UT, USA; 2McKay-Dee Hospital Center, Ogden, UT, USA; 3Institute for Healthcare Delivery Research, Salt Lake City, UT, USA and 4Divisions of Neonatology and Pediatric Gastroenterology, Departments of Pediatrics, Cell Biology, and Pathology, University of Alabama at Birmingham, Birmingham, AL, USA Introduction Objective: Blood concentrations of eosinophils and monocytes are part Normal values for hematological parameters are not generally of the complete blood count. Reference ranges for these concentrations during available for neonates because blood is not drawn on healthy the neonatal period, established by very large sample sizes and modern neonates to establish normal ranges. Instead, ‘reference ranges’ are methods, are needed for identifying abnormally low or high values. used in neonatal hematology.1–6 These consist of the 5th to 95th Study Design: We constructed reference ranges for eosinophils per ml percentile values assembled from large numbers of neonates with and monocytes per ml among neonates of 22 to 42 weeks of gestation, minimal pathology or with pathology not thought to be relevant to on the day of birth, and also during 28 days after birth. Data were the laboratory parameter under study. Recent examples of their obtained from archived electronic records over an eight and one-half-year usefulness include the following: Reference ranges for erythrocyte period in a multihospital health-care system. -
Eosinophil Extracellular Traps and Inflammatory Pathologies—Untangling the Web!
REVIEW published: 26 November 2018 doi: 10.3389/fimmu.2018.02763 Eosinophil Extracellular Traps and Inflammatory Pathologies—Untangling the Web! Manali Mukherjee 1*, Paige Lacy 2 and Shigeharu Ueki 3 1 Department of Medicine, McMaster University and St Joseph’s Healthcare, Hamilton, ON, Canada, 2 Department of Medicine, Alberta Respiratory Centre, University of Alberta, Edmonton, AB, Canada, 3 Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine, Akita, Japan Eosinophils are an enigmatic white blood cell, whose immune functions are still under intense investigation. Classically, the eosinophil was considered to fulfill a protective role against parasitic infections, primarily large multicellular helminths. Although eosinophils are predominantly associated with parasite infections, evidence of a role for eosinophils in mediating immunity against bacterial, viral, and fungal infections has been recently reported. Among the mechanisms by which eosinophils are proposed to exert their protective effects is the production of DNA-based extracellular traps (ETs). Remarkably, Edited by: DNA serves a role that extends beyond its biochemical function in encoding RNA and Moncef Zouali, protein sequences; it is also a highly effective substance for entrapment of bacteria Institut National de la Santé et de la and other extracellular pathogens, and serves as valuable scaffolding for antimicrobial Recherche Médicale (INSERM), France mediators such as granule proteins from immune cells. Extracellular -
Eosinophil Response Against Classical and Emerging
REVIEWS Eosinophil Response Against Classical and Emerging Respiratory Viruses: COVID-19 Rodrigo-Muñoz JM1,2, Sastre B1,2, Cañas JA1,2, Gil-Martínez M1, Redondo N1, del Pozo V1,2 1Immunology Department, Instituto de Investigación Sanitaria (IIS) Fundación Jiménez Díaz, Madrid, Spain 2CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain J Investig Allergol Clin Immunol 2021; Vol. 31(2): 94-107 doi: 10.18176/jiaci.0624 Abstract Eosinophils were discovered more than 140 years ago. These polymorphonuclear leukocytes have a very active metabolism and contain numerous intracellular secretory granules that enable multiple effects on both health and disease status. Classically, eosinophils have been considered important immune cells in the pathogenesis of inflammatory processes (eg, parasitic helminth infections) and allergic or pulmonary diseases (eg, asthma) and are always associated with a type 2 immune response. Furthermore, in recent years, eosinophils have been linked to the immune response by conferring host protection against fungi, bacteria, and viruses, which they recognize through several molecules, such as toll-like receptors and the retinoic acid–inducible gene 1–like receptor. The immune protection provided by eosinophils is exerted through multiple mechanisms and properties. Eosinophils contain numerous cytoplasmatic granules that release cationic proteins, cytokines, chemokines, and other molecules, all of which contribute to their functioning. In addition to the competence of eosinophils as effector cells, their capabilities as antigen-presenting cells enable them to act in multiple situations, thus promoting diverse aspects of the immune response. This review summarizes various aspects of eosinophil biology, with emphasis on the mechanisms used and roles played by eosinophils in host defence against viral infections and response to vaccines. -
Detailed Structure and Pathophysiological Roles of the Iga-Albumin Complex in Multiple Myeloma
International Journal of Molecular Sciences Article Detailed Structure and Pathophysiological Roles of the IgA-Albumin Complex in Multiple Myeloma Yuki Kawata 1, Hisashi Hirano 1, Ren Takahashi 1, Yukari Miyano 1, Ayuko Kimura 1, Natsumi Sato 1, Yukio Morita 2, Hirokazu Kimura 1,* and Kiyotaka Fujita 1 1 Department of Health Sciences, Gunma Paz University Graduate School of Health Sciences, 1-7-1, Tonyamachi, Takasaki-shi, Gunma 370-0006, Japan; [email protected] (Y.K.); [email protected] (H.H.); [email protected] (R.T.); [email protected] (Y.M.); [email protected] (A.K.); [email protected] (N.S.); [email protected] (K.F.) 2 Laboratory of Public Health II, Azabu University School of Veterinary Medicine, 1-17-71, Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-27-365-3366; Fax: +81-27-388-0386 Abstract: Immunoglobulin A (IgA)-albumin complexes may be associated with pathophysiology of multiple myeloma, although the etiology is not clear. Detailed structural analyses of these protein– protein complexes may contribute to our understanding of the pathophysiology of this disease. We analyzed the structure of the IgA-albumin complex using various electrophoresis, mass spectrom- etry, and in silico techniques. The data based on the electrophoresis and mass spectrometry showed that IgA in the sera of patients was dimeric, linked via the J chain. Only dimeric IgA can bind to albumin molecules leading to IgA-albumin complexes, although both monomeric and dimeric forms of IgA were present in the sera. -
Allergen-Specific Igg1 and Igg3 Through Fc Gamma RII Induce Eosinophil Degranulation
Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation. M Kaneko, … , G J Gleich, H Kita J Clin Invest. 1995;95(6):2813-2821. https://doi.org/10.1172/JCI117986. Research Article Evidence suggests that eosinophils contribute to inflammation in bronchial asthma by releasing chemical mediators and cytotoxic granule proteins. To investigate the mechanism of eosinophil degranulation in asthma, we established an in vitro model of allergen-induced degranulation. We treated tissue culture plates with short ragweed pollen (SRW) extract and sera from either normal donors or SRW-sensitive patients with asthma. Eosinophils were incubated in the wells and degranulation was assessed by measurement of eosinophil-derived neurotoxin in supernatants. We detected degranulation only when sera from SRW-sensitive patients were reacted with SRW. Anti-IgG and anti-Fc gamma RII mAb, but not anti-IgE or anti-Fc epsilon RII mAb, abolished the degranulation. IgG-depleted serum did not induce degranulation; IgE-depleted serum triggered as much degranulation as untreated serum. Furthermore, serum levels of SRW-specific IgG1 or IgG3 correlated with the amounts of released eosinophil-derived neurotoxin. When eosinophils were cultured in wells coated with purified IgG or IgE, eosinophil degranulation was observed only with IgG. Finally, human IgG1 and IgG3, and less consistently IgG2, but not IgG4, induced degranulation. Thus, sera from patients with SRW-sensitive asthma induce eosinophil degranulation in vitro through antigen-specific IgG1 and IgG3 antibodies. These antibodies may be responsible for degranulation of eosinophils in inflammatory reactions, such as bronchial asthma. Find the latest version: https://jci.me/117986/pdf Allergen-specific IgG1 and IgG3 through FcRIl Induce Eosinophil Degranulation Masayuki Kaneko, Mark C. -
Effect of Recombinant Granulocyte Colony-Stimulating Factor on Blood
Original ..............Article Effect of Recombinant Granulocyte Colony-Stimulating Factor on Blood Neutrophil Concentrations among Patients with ‘‘Idiopathic Neonatal Neutropenia’’: A Randomized, Placebo-controlled Trial Sandra E. Juul, MD, PhD INTRODUCTION Robert D. Christensen, MD A severe but self-limited idiopathic variety of neutropenia, termed ‘‘idiopathic neonatal neutropenia’’, has been described among preterm infants.1,2 Neonates with this condition have several features in common, including the fact that no specific variety of OBJECTIVES: neutropenia is diagnosed, it often appears late in the clinical We previously described a severe, prolonged, idiopathic, but self-resolving, course, can be quite prolonged, and generally occurs in otherwise variety of neutropenia among preterm neonates. In the present study, we well infants.1,2 It is not clear whether this condition is a single sought to assess the marrow neutrophil reserves of these patients by entity or represents multiple disorders with the common feature of serially measuring blood neutrophils following the administration of severe but self-limited neutropenia. As neutropenia in preterm recombinant granulocyte colony-stimulating factor (rG-CSF) or placebo. infants can be a sign of incipient severe illness, particularly sepsis, STUDY DESIGN: this variety of neutropenia in the neonatal intensive care unit (NICU) often causes concern, and sometimes prompts evaluations Prospective, randomized trial of rG-CSF vs placebo for infants with for infection and repeated or prolonged -
Different Innate and Adaptive Immune Response to SARS-Cov-2 Infection of Asymptomatic, Mild and Severe Cases
medRxiv preprint doi: https://doi.org/10.1101/2020.06.22.20137141; this version posted September 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Title: Different innate and adaptive immune response to SARS-CoV-2 infection of asymptomatic, mild and severe cases Rita Carsetti1,2*, Salvatore Zaffina3,4, Eva Piano Mortari1#, Sara Terreri1#, Francesco Corrente2, Claudia Capponi2, Patrizia Palomba2, Mattia Mirabella2, Simona Cascioli5, Paolo Palange6, Ilaria Cuccaro6, Cinzia Milito7, Alimuddin Zumla8,9, Markus Maeurer10,11, Vincenzo Camisa3,4, Maria Rosaria Vinci3,4, Annapaola Santoro3,4, Eleonora Cimini12, Luisa Marchioni13, Emanuele Nicastri13, Fabrizio Palmieri13, Chiara Agrati12, Giuseppe Ippolito14, Ottavia Porzio15,16, Carlo Concato17, Andrea Onetti Muda18, Massimiliano Raponi4, Concetta Quintarelli19,20, Isabella Quinti7, Franco Locatelli19,21 Affiliations: 1B Cell Pathophysiology Unit, Immunology Research Area, Bambino Gesù Children's Hospital IRCCS, Rome, Italy; 2Diagnostic Immunology Unit, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy 3Occupational Medicine/Health Technology Assessment and Safety Research Unit, Clinical- Technological Innovations Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy 4Health Directorate, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy 5Research Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy 6Department of Public Health and infectious diseases pulmonary division, Policlinico Umberto I Hospital, Rome, Italy. 7Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. -
Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL Or ALL
cells Article Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL Felix Korell 1,*, Sascha Laier 2, Sandra Sauer 1, Kaya Veelken 1, Hannah Hennemann 1, Maria-Luisa Schubert 1, Tim Sauer 1, Petra Pavel 2, Carsten Mueller-Tidow 1, Peter Dreger 1, Michael Schmitt 1 and Anita Schmitt 1 1 Department of Internal Medicine V, University Hospital Heidelberg, 69120 Heidelberg, Germany; [email protected] (S.S.); [email protected] (K.V.); [email protected] (H.H.); [email protected] (M.-L.S.); [email protected] (T.S.); [email protected] (C.M.-T.); [email protected] (P.D.); [email protected] (M.S.); [email protected] (A.S.) 2 Institute of Clinical Transfusion Medicine and Cell Therapy (IKTZ), 89081 Heidelberg, Germany; [email protected] (S.L.); [email protected] (P.P.) * Correspondence: [email protected] Received: 9 April 2020; Accepted: 13 May 2020; Published: 15 May 2020 Abstract: Background: T lymphocyte collection through leukapheresis is an essential step for chimeric antigen receptor T (CAR-T) cell therapy. Timing of apheresis is challenging in heavily pretreated patients who suffer from rapid progressive disease and receive T cell impairing medication. Methods: A total of 75 unstimulated leukaphereses were analyzed including 45 aphereses in patients and 30 in healthy donors. Thereof, 41 adult patients with Non-Hodgkin’s lymphoma (85%) or acute lymphoblastic leukemia (15%) underwent leukapheresis for CAR-T cell production. -
An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in Vitro
fimmu-11-00532 April 24, 2020 Time: 17:59 # 1 ORIGINAL RESEARCH published: 28 April 2020 doi: 10.3389/fimmu.2020.00532 An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in vitro Mareike Ohms, Sonja Möller and Tamás Laskay* Department of Infectious Diseases and Microbiology, University of Lübeck, Lübeck, Germany Neutrophils act as the first line of defense against invading pathogens. Although traditionally considered in context of their antimicrobial effector functions, the importance of tumor-associated neutrophils (TANs) in the development of cancer has become increasingly clear during the last decade. With regard to their high plasticity, neutrophils were shown to acquire an anti-tumorigenic N1 or a pro-tumorigenic N2 phenotype. Despite the urgent need to get a comprehensive understanding of the interaction of TANs with their tumor microenvironment, most studies still rely on murine tumor models. Here we present for the first time a polarization attempt to generate N1 and N2 neutrophils from primary human neutrophils in vitro. Our results underscore Edited by: that N1-polarized neutrophils have a pro-inflammatory phenotype characterized among Martin Herrmann, University Hospital Erlangen, Germany others by a higher level of intercellular adhesion molecule (ICAM)-1 and high secretion Reviewed by: of interferon (IFN)g-induced protein 10 (IP-10)/C-X-C motif chemokine 10 (CXCL10) Payel Sil, and tumor necrosis factor (TNF). Further, we demonstrate that neutrophils incubated National Institute of Environmental under a tumor-mimicking in vitro environment show a high cell surface expression of Health Sciences (NIEHS), United States C-X-C motif chemokine receptor 2 (CXCR2) and secrete high levels of interleukin (IL)- Mihaela Gadjeva, 8. -
The Term Meaning White Blood Cells Is
The Term Meaning White Blood Cells Is Micro Angelico still desalinate: venatic and unclimbed Elliot originate quite significatively but globes her proximocracoviennes and admeasuring catechetically. politely. Welsh Hazardableis attritional orand pollened, endows Sherwood voicelessly never as statant comb-outs Ira interpenetrates any output! Trophoblast cells are destined to give rise to many of the extraembryonic tissues. Genetic disorders and blood the cells is a permanent hair shaft, great care provider first line reported by lab technician may be included in circulation, the superficial veins. The part of the brain that controls coordinated movement. What Is A Medical Technologist? Inflammation of the liver. MPV is used along with platelet count to diagnose some diseases. After circulating in the bloodstream for about a day, monocytes enter body tissues to become macrophages, which can destroy some germs by surrounding and digesting them. The legacy of this great resource continues as the Merck Veterinary Manual in the US and Canada and the MSD Manual outside of North America. An abnormal increase in the volume of circulating blood. These small cells seem to sound an alarm when infectious agents invade your blood. Comparisons may be useful for a differential diagnosis. Finally, emotional or physical stress can also cause elevated white blood cell counts. The ability of the body to learn to fight specific infections after being exposed to the germs that cause them. However, you may also visit the Cookie Settings at any time to provide controlled consent, and you can withdraw your consent there. Severe pain that occurs suddenly and usually lasts a short while. -
The Role of Eosinophils and Basophils in Allergic Diseases Considering Genetic Findings
The role of eosinophils and basophils in allergic diseases considering genetic findings. Rachel Nadif, Farid Zerimech, Emmanuelle Bouzigon, Regis Matran To cite this version: Rachel Nadif, Farid Zerimech, Emmanuelle Bouzigon, Regis Matran. The role of eosinophils and ba- sophils in allergic diseases considering genetic findings.. Current Opinion in Allergy and Clinical Im- munology, Lippincott, Williams & Wilkins, 2013, 13 (5), pp.507-13. 10.1097/ACI.0b013e328364e9c0. inserm-00880260 HAL Id: inserm-00880260 https://www.hal.inserm.fr/inserm-00880260 Submitted on 3 Oct 2014 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. The role of eosinophils and basophils in allergic diseases considering genetic findings Rachel Nadifa,b, Farid Zerimechc,d, Emmanuelle Bouzigone,f, Regis Matranc,d Affiliations: aInserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Respiratory and Environmental Epidemiology Team, F-94807, Villejuif, France bUniv Paris-Sud, UMRS 1018, F-94807, Villejuif, France cCHRU de Lille, F-59000, Lille, France dUniv Lille Nord de France, EA4483, F-59000, Lille, France eUniv Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d’Hématologie, F-75007, Paris, France fInserm, UMR-946, F-75010, Paris, France Correspondence to Rachel Nadif, PhD, Inserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Respiratory and Environmental Epidemiology Team, F-94807, Villejuif, France. -
What You Need to Know About Innate Immunity
WhatWhat youyou needneed toto knowknow aboutabout innateinnate immunityimmunity JenniferJennifer KoKo MD,MD, PhDPhD ClevelandCleveland ClinicClinic Immunology/PathologyImmunology/Pathology andand LaboratoryLaboratory MedicineMedicine InnateInnate ImmunityImmunity FirstFirst lineline ofof defense,defense, immediateimmediate defensedefense DayDay toto dayday protectionprotection OnlyOnly whenwhen innateinnate defensedefense bypassed,bypassed, evadedevaded oror overwhelmedoverwhelmed isis adaptiveadaptive immunityimmunity requiredrequired NonNon--specificspecific RecognizeRecognize pathogenspathogens inin aa genericgeneric wayway DoesDoes notnot conferconfer longlong lastinglasting oror protectiveprotective immunityimmunity toto hosthost EvolutionarilyEvolutionarily older,older, foundfound inin primitiveprimitive organismsorganisms InnateInnate ImmunityImmunity andand InflammationInflammation 1)1) RespondRespond rapidlyrapidly toto tissuetissue damagedamage physicalphysical andand chemicalchemical barrierbarrier recruitmentrecruitment ofof immuneimmune cellscells toto sitesite ofof injuryinjury 2)2) LimitLimit spreadspread ofof infectioninfection identificationidentification andand removalremoval ofof foreignforeign substancessubstances activationactivation ofof thethe complementcomplement cascadecascade activationactivation ofof coagulationcoagulation cascadecascade 3)3) InitiateInitiate adaptiveadaptive immuneimmune responseresponse antigenantigen presentationpresentation andand cytokinecytokine productionproduction 4)4)